KRT5 and ovarian serous adenocarcinoma: Furthermore, treatment with an IC50 dose of carboplatin significantly increased the number of K5+ cells in 4 serous ovarian cancer cell lines (OVCAR-5, OVCAR-3, OAW28 and COV362) (Figure 5C and 5D).